This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Erin DeVay Henitz: Innovator in Cancer Treatment Prediction
Introduction
Erin DeVay Henitz is a notable inventor based in Flemington, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on predicting responses to cancer treatments, which can greatly enhance patient care and treatment efficacy.
Latest Patents
Erin holds 1 patent for his invention titled "Predictors for cancer treatment." This invention provides methods for predicting a patient's response to cancer treatment by determining CD68 levels or PSMB1 (P11A) polymorphism in a biological sample. Additionally, it identifies the presence or quantity of a second biomarker in the patient. The invention also includes kits and methods for treating cancer, showcasing its practical application in medical settings.
Career Highlights
Erin DeVay Henitz is currently employed at Janssen Pharmaceutica NV, a company known for its commitment to developing innovative pharmaceutical solutions. His role at Janssen allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout his career, Erin has worked alongside talented colleagues, including Weimin Li and Deborah Ricci. Their collaborative efforts have further advanced the research and development of cancer treatment methodologies.
Conclusion
Erin DeVay Henitz is a pioneering inventor whose work in cancer treatment prediction is making a significant impact in the medical field. His innovative approaches and collaborations are paving the way for improved patient outcomes in cancer therapy.